BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 29498659)

  • 1. Investigation of an
    Schröder S; Wenzel B; Deuther-Conrad W; Teodoro R; Kranz M; Scheunemann M; Egerland U; Höfgen N; Briel D; Steinbach J; Brust P
    Molecules; 2018 Mar; 23(3):. PubMed ID: 29498659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, 18F-Radiolabelling and Biological Characterization of Novel Fluoroalkylated Triazine Derivatives for in Vivo Imaging of Phosphodiesterase 2A in Brain via Positron Emission Tomography.
    Schröder S; Wenzel B; Deuther-Conrad W; Teodoro R; Egerland U; Kranz M; Scheunemann M; Höfgen N; Steinbach J; Brust P
    Molecules; 2015 May; 20(6):9591-615. PubMed ID: 26016549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiosynthesis and Biological Investigation of a Novel Fluorine-18 Labeled Benzoimidazotriazine- Based Radioligand for the Imaging of Phosphodiesterase 2A with Positron Emission Tomography.
    Ritawidya R; Wenzel B; Teodoro R; Toussaint M; Kranz M; Deuther-Conrad W; Dukic-Stefanovic S; Ludwig FA; Scheunemann M; Brust P
    Molecules; 2019 Nov; 24(22):. PubMed ID: 31731831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical Evaluation of 18F-PF-05270430, a Novel PET Radioligand for the Phosphodiesterase 2A Enzyme.
    Chen L; Nabulsi N; Naganawa M; Zasadny K; Skaddan MB; Zhang L; Najafzadeh S; Lin SF; Helal CJ; Boyden TL; Chang C; Ropchan J; Carson RE; Villalobos A; Huang Y
    J Nucl Med; 2016 Sep; 57(9):1448-53. PubMed ID: 27199356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and In Vitro Evaluation of 8-Pyridinyl-Substituted Benzo[
    Ritawidya R; Ludwig FA; Briel D; Brust P; Scheunemann M
    Molecules; 2019 Jul; 24(15):. PubMed ID: 31370274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and preclinical evaluation of an 18F labeled PDE7 inhibitor for PET neuroimaging.
    Thomae D; Servaes S; Vazquez N; Wyffels L; Dedeurwaerdere S; Van der Veken P; Joossens J; Augustyns K; Stroobants S; Staelens S
    Nucl Med Biol; 2015 Dec; 42(12):975-81. PubMed ID: 26330158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and selection parameters to accelerate the discovery of novel central nervous system positron emission tomography (PET) ligands and their application in the development of a novel phosphodiesterase 2A PET ligand.
    Zhang L; Villalobos A; Beck EM; Bocan T; Chappie TA; Chen L; Grimwood S; Heck SD; Helal CJ; Hou X; Humphrey JM; Lu J; Skaddan MB; McCarthy TJ; Verhoest PR; Wager TT; Zasadny K
    J Med Chem; 2013 Jun; 56(11):4568-79. PubMed ID: 23651455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First-in-Human Assessment of the Novel PDE2A PET Radiotracer 18F-PF-05270430.
    Naganawa M; Waterhouse RN; Nabulsi N; Lin SF; Labaree D; Ropchan J; Tarabar S; DeMartinis N; Ogden A; Banerjee A; Huang Y; Carson RE
    J Nucl Med; 2016 Sep; 57(9):1388-95. PubMed ID: 27103022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiosynthesis and Preclinical Evaluation of an
    Wenzel B; Fritzsche SR; Toussaint M; Briel D; Kopka K; Brust P; Scheunemann M; Deuther-Conrad W
    Pharmaceuticals (Basel); 2022 Oct; 15(10):. PubMed ID: 36297384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-Activity Relationship Studies of Pyridine-Based Ligands and Identification of a Fluorinated Derivative for Positron Emission Tomography Imaging of Cannabinoid Type 2 Receptors.
    Haider A; Kretz J; Gobbi L; Ahmed H; Atz K; Bürkler M; Bartelmus C; Fingerle J; Guba W; Ullmer C; Honer M; Knuesel I; Weber M; Brink A; Herde AM; Keller C; Schibli R; Mu L; Grether U; Ametamey SM
    J Med Chem; 2019 Dec; 62(24):11165-11181. PubMed ID: 31751140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical evaluation of [(18)F]JNJ42259152 as a PET tracer for PDE10A.
    Celen S; Koole M; Ooms M; De Angelis M; Sannen I; Cornelis J; Alcazar J; Schmidt M; Verbruggen A; Langlois X; Van Laere K; Andrés JI; Bormans G
    Neuroimage; 2013 Nov; 82():13-22. PubMed ID: 23664955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploration of the impact of stereochemistry on the identification of the novel translocator protein PET imaging agent [(18)F]GE-180.
    Chau WF; Black AM; Clarke A; Durrant C; Gausemel I; Khan I; Mantzilas D; Oulie I; Rogstad A; Trigg W; Jones PA
    Nucl Med Biol; 2015 Sep; 42(9):711-9. PubMed ID: 26072270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of a fluorinated 4-oxo-quinoline derivative as a potential positron emission tomography radiotracer for imaging cannabinoid receptor type 2.
    Slavik R; Müller Herde A; Haider A; Krämer SD; Weber M; Schibli R; Ametamey SM; Mu L
    J Neurochem; 2016 Sep; 138(6):874-86. PubMed ID: 27385045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiosynthesis and biological evaluation of the new PDE10A radioligand [
    Wagner S; Teodoro R; Deuther-Conrad W; Kranz M; Scheunemann M; Fischer S; Wenzel B; Egerland U; Hoefgen N; Steinbach J; Brust P
    J Labelled Comp Radiopharm; 2017 Jan; 60(1):36-48. PubMed ID: 27896836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Target Engagement of a Phosphodiesterase 2A Inhibitor Affecting Long-Term Memory in the Rat.
    Gu G; Scott T; Yan Y; Warren N; Zhang A; Tabatabaei A; Xu H; Aertgeerts K; Gomez L; Morse A; Li YW; Breitenbucher JG; Massari E; Vivian J; Danks A
    J Pharmacol Exp Ther; 2019 Sep; 370(3):399-407. PubMed ID: 31253692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and evaluation of novel ¹⁸F labeled 2-pyridinylbenzoxazole and 2-pyridinylbenzothiazole derivatives as ligands for positron emission tomography (PET) imaging of β-amyloid plaques.
    Cui M; Wang X; Yu P; Zhang J; Li Z; Zhang X; Yang Y; Ono M; Jia H; Saji H; Liu B
    J Med Chem; 2012 Nov; 55(21):9283-96. PubMed ID: 22974116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and preliminary evaluation of 18F-labeled pyridaben analogues for myocardial perfusion imaging with PET.
    Mou T; Zhao Z; Fang W; Peng C; Guo F; Liu B; Ma Y; Zhang X
    J Nucl Med; 2012 Mar; 53(3):472-9. PubMed ID: 22302832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo evaluation of [18F]-FDEGPECO as a PET tracer for imaging the metabotropic glutamate receptor subtype 5 (mGluR5).
    Wanger-Baumann CA; Mu L; Honer M; Belli S; Alf MF; Schubiger PA; Krämer SD; Ametamey SM
    Neuroimage; 2011 Jun; 56(3):984-91. PubMed ID: 21406237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting cyclic nucleotide phosphodiesterase 5 (PDE5) in brain: Toward the development of a PET radioligand labeled with fluorine-18.
    Wenzel B; Liu J; Dukic-Stefanovic S; Deuther-Conrad W; Teodoro R; Ludwig FA; Chezal JM; Moreau E; Brust P; Maisonial-Besset A
    Bioorg Chem; 2019 May; 86():346-362. PubMed ID: 30753989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphodiesterase 2A localized in the spinal cord contributes to inflammatory pain processing.
    Kallenborn-Gerhardt W; Lu R; Bothe A; Thomas D; Schlaudraff J; Lorenz JE; Lippold N; Real CI; Ferreirós N; Geisslinger G; Del Turco D; Schmidtko A
    Anesthesiology; 2014 Aug; 121(2):372-82. PubMed ID: 24758774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.